The diagnosis of CHI is based on clinical findings and hypoglycemic events, combined with inappropriately high insulin or C-peptide levels or low insulinlike growth factor– binding protein 1 levels (4,5). This evidence concerns the gene INS and congenital isolated hyperinsulinism.